High-risk patients with hypertension: Are we doing enough?

被引:1
|
作者
Chiao, Evelyn [1 ]
Sobolski, John [4 ]
Krienke, Russ [2 ]
Wong, Ken S. [3 ]
Dastani, Homa B. [3 ]
Nightengale, Brian [1 ]
机构
[1] Xcenda, Palm Harbor, FL 34685 USA
[2] Austin Reg Clin, Austin, TX USA
[3] Novartis Pharmaceut, Evidence Based Med, E Hanover, NJ USA
[4] Advocate Hlth Care, Cardiol Sect, Chicago, IL USA
关键词
Blood pressure control; comorbid; obese; advanced age;
D O I
10.1016/j.jash.2008.04.010
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Despite the increasing risk of cardiovascular disease, especially in patients with multiple risk factors, blood pressure (BP) control remains suboptimal. This Study investigated real-world BP goal attainment and prescribing patterns for high-risk patients. A retrospective chart review study was conducted in patients treated by eight large primary care physician group practices between December 2003 and May 2006. A total of 1,917 hypertensive patients were identified with; >= 1 risk factors: African-Amnerican ethnicity (634); diabetes (851); advanced age (1,123); body mass index (BMI) 25 kg/m(2) (1,614). BP control rate was 46% overall, and similar in the advanced age and overweight/obese subpopulations, but substantially lower (28%) in the diabetic subpopulation. Systolic blood pressure; >= 20 mm Hg above the Joint National Committee on Prevention, Detection, Evaluation, and Treatment Report recommendation was found in 13% of the overall, advanced age and overweight/obese subpopulations, and in 20% of diabetics and 18% of African-Americans. Overall, 62% of patients received >= 2 anti hypertensive while 36% of diabetics, 31% of African-Americans, 28% of advanced age, and 26% of overweight/obese patients received >= 3 antihypertensive classes. Despite availability of multiple antihypertensive classes, BP control rates were still suboptimal in this study's high-risk patients. There is a need for awareness and more aggressive treatment in high-risk patients given their increased risk of poor outcomes. J Am Soc Hypertens 2008;2(5): 385-392. (C) 2008 American Society of Hypertension. All rights reserved.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 50 条
  • [31] Response by Sarfo to letter regarding "Patients with hypertension and/or diabetes and incident stroke: A risk assessment"
    Sarfo, Fred S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 403 : 163 - 164
  • [32] Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension
    Rendina, Domenico
    Ippolito, Renato
    De Filippo, Gianpaolo
    Muscariello, Riccardo
    De Palma, Daniela
    De Bonis, Silvana
    di Cola, Michele Schiano
    Benvenuto, Domenico
    Galderisi, Maurizio
    Strazzullo, Pasquale
    Galletti, Ferruccio
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (02) : 171 - 179
  • [33] Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension
    Domenico Rendina
    Renato Ippolito
    Gianpaolo De Filippo
    Riccardo Muscariello
    Daniela De Palma
    Silvana De Bonis
    Michele Schiano di Cola
    Domenico Benvenuto
    Maurizio Galderisi
    Pasquale Strazzullo
    Ferruccio Galletti
    Internal and Emergency Medicine, 2017, 12 : 171 - 179
  • [34] Relationship of Blood Pressure Control and Hospitalization Risk to Medication Adherence Among Patients With Hypertension in Taiwan
    Wu, Pin-Hsuan
    Yang, Chuh-Yuh
    Yao, Zhi-Lian
    Lin, Wei-Zhan
    Wu, Li-Wei
    Chang, Chih-Ching
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (02) : 155 - 160
  • [35] Cardiovascular Risk Profile in 14 513 Patients with Essential Hypertension Followed by Italian Specialist Physicians
    Giuliano Tocci
    Bruno Trimarco
    Giuseppe Mancia
    Massimo Volpe
    High Blood Pressure & Cardiovascular Prevention, 2004, 11 (4) : 165 - 173
  • [36] Nutraceuticals for Blood Pressure Control in Patients with High-Normal or Grade 1 Hypertension
    Valentina Trimarco
    Claudia Sara Cimmino
    Mario Santoro
    Gianpiero Pagnano
    Maria Virginia Manzi
    Anna Piglia
    Caterina Anna Giudice
    Nicola De Luca
    Raffaele Izzo
    High Blood Pressure & Cardiovascular Prevention, 2012, 19 (3) : 117 - 122
  • [37] Nutraceuticals for Blood Pressure Control in Patients with High-Normal or Grade 1 Hypertension
    Trimarco, Valentina
    Cimmino, Claudia Sara
    Santoro, Mario
    Pagnano, Gianpiero
    Manzi, Maria Virginia
    Piglia, Anna
    Giudice, Caterina Anna
    De Luca, Nicola
    Izzo, Raffaele
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2012, 19 (03) : 117 - 122
  • [38] Control Status of Atherosclerotic Cardiovascular Risk Factors Among Japanese High-Risk Subjects: Analyses of a Japanese Health Check Database from 2008 to 2011
    Hasegawa, Koji
    Tsukamoto, Kazuhisa
    Kunimi, Motoei
    Asahi, Koichi
    Iseki, Kunitoshi
    Moriyama, Toshiki
    Yamagata, Kunihiro
    Tsuruya, Kazuhiko
    Fujimoto, Shouichi
    Narita, Ichiei
    Konta, Tsuneo
    Kondo, Masahide
    Kimura, Kenjiro
    Ohashi, Yasuo
    Watanabe, Tsuyoshi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (08) : 991 - +
  • [39] Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice
    Mancia, G
    Pessina, AC
    Trimarco, B
    Grassi, G
    JOURNAL OF HYPERTENSION, 2004, 22 (12) : 2387 - 2396
  • [40] Comments: Absolute cardiovascular risk assessment for guiding antihypertensive prescribing in Australian primary care patients with hypertension
    Bezabhe, Woldesellassie M.
    Peterson, Gregory M.
    JOURNAL OF HUMAN HYPERTENSION, 2023, 37 (06) : 426 - 427